Angina

Clinical Trial Finder

Many patients with angina are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT

Conditions:   Coronary Artery Disease;   Stable Angina Pectoris;   Unstable Angina Pectoris
Interventions:   Device: BuMA Supreme™ stent;   Device: Xience V/Prime stent
Sponsor:   Sino Medical Sciences Technology Inc.
Not yet recruiting - verified April 2016

Postapproval Trial On Carotid Stenting in Patients With High Risk Vs Standard Risk for Open Carotid Endarterectomy(REAL)

Condition:   Carotid Artery Diseases
Intervention:  
Sponsor:   Joaquin de Haro, M.D.
Completed - verified April 2016

Positive Psychology for ACS Patients: a Factorial Design Study

Condition:   Acute Coronary Syndrome
Interventions:   Other: Positive Psychology (PP);   Other: Motivational Interviewing (MI)
Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2016

Brazilian Registry of Acute SItuations in Emergency Department - BRASIED Registry

Conditions:   Acute Coronary Syndromes;   Heart Failure;   Pulmonary Edema;   Aortic Aneurysm, Familial Thoracic 1;   Chest Pain;   Pulmonary Embolism;   Syncope
Intervention:   Other: no intervention
Sponsor:   University of Sao Paulo General Hospital
Recruiting - verified April 2016

Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease

Conditions:   Non ST Elevation Acute Coronary Syndromes;   Stable Coronary Syndromes;   NSTEMI;   Unstable Angina
Intervention:  
Sponsors:   Italian Society of Invasive Cardiology;   IRCCS Policlinico S. Matteo
Recruiting - verified April 2016

Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes?

Condition:   Acute Coronary Syndrome
Intervention:   Procedure: Percutaneous coronary intervention for revascularization
Sponsor:   Assistance Publique Hopitaux De Marseille
Recruiting - verified April 2016

Researching the Diagnosis and Treatment of Targeting Nano microRNA in the Patients of Acute Coronary Syndrome

Conditions:   Acute Coronary Syndrome;   Septic Shock
Intervention:  
Sponsor:   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Active, not recruiting - verified April 2016

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes

Conditions:   Diabetes;   Diabetes Mellitus, Type 2
Interventions:   Drug: semaglutide;   Drug: placebo
Sponsor:   Novo Nordisk A/S
Not yet recruiting - verified April 2016

A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease

Condition:   Prostate Cancer
Interventions:   Drug: Degarelix;   Drug: Leuprolide
Sponsors:   Ferring Pharmaceuticals;   Memorial Sloan Kettering Cancer Center;   Duke Clinical Research Institute
Recruiting - verified April 2016

Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy

Conditions:   Angina, Stable;   Angina, Unstable;   Anticoagulants
Interventions:   Device: COBRA PzF;   Device: DES
Sponsor:   CeloNova BioSciences, Inc.
Recruiting - verified April 2016

Treadmill CV Safety Study

Condition:   Stable Angina
Interventions:   Drug: AMG 334;   Drug: Placebo
Sponsor:   Amgen
Recruiting - verified April 2016

Boston Scientific COMET Wire Validation Study

Condition:   Stable Angina
Interventions:   Device: Boston Scientific Pressure Wire;   Device: Validation of Boston Scientific pressure wire
Sponsors:   University Hospital Southampton NHS Foundation Trust.;   Liverpool Heart and Chest Hospital NHS Foundation Trust;   Boston Scientific Corporation
Recruiting - verified April 2016

More Intensive Cardiac Rehabilitation Programs in Less Time

Condition:   Acute Coronary Syndrome
Intervention:   Other: Intensive cardiac rehabilitation program in less time
Sponsor:   Almudena Castro Conde
Recruiting - verified April 2016

CER-001 Atherosclerosis Regression ACS Trial

Condition:   Acute Coronary Syndromes
Interventions:   Drug: CER-001;   Drug: Placebo
Sponsors:   Cerenis Therapeutics, SA;   South Australian Health and Medical Research Institute
Recruiting - verified April 2016

Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome

Conditions:   Diabetes Mellitus;   Acute Coronary Syndrome;   Coronary Artery Disease
Interventions:   Drug: Novel strategy Aspirin;   Drug: Conventional strategy Aspirin
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Bayer
Not yet recruiting - verified April 2016

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Condition:   Acute Coronary Syndromes
Interventions:   Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
Sponsors:   Bristol-Myers Squibb;   Pfizer;   Duke Clinical Research Institute
Recruiting - verified April 2016

Mechanisms of Social Inequalities in Post-hospitalization Rehabilitation in Patients With Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   Nordsjaellands Hospital
Active, not recruiting - verified April 2016

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Acetylsalicylic acid;   Drug: Rivaroxaban;   Drug: Clopidogrel;   Drug: Ticagrelor
Sponsors:   Janssen Research & Development, LLC;   Bayer;   Duke Clinical Research Institute;   Harvard Medical School
Recruiting - verified April 2016

Trajectory of Positive Psychological States in Patients With ACS

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2016

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

Condition:   Acute Coronary Syndromes
Intervention:   Other: Non-Interventional Study
Sponsor:   AstraZeneca
Recruiting - verified April 2016

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Condition:   Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions:   Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
Sponsors:   AstraZeneca;   Cleveland Clinic Coordinating Center for Clinical Research (C5R);   Quintiles, Inc.
Recruiting - verified April 2016

BIOFLOW III Asia Registry

Conditions:   Coronary Artery Disease;   Myocardial Ischemia;   Diabetes Mellitus Type 1 or 2
Intervention:  
Sponsor:   BIOTRONIK Asia Pacific Pte Ltd
Active, not recruiting - verified April 2016

Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Placebo;   Drug: Linagliptin
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Recruiting - verified April 2016

The TRUST Study - Depression Substudy

Conditions:   Subclinical Hypothyroidism;   Depression
Interventions:   Drug: Levothyroxine;   Drug: Placebo
Sponsors:   University Hospital Inselspital, Berne;   Leiden University Medical Center;   University of Bern
Recruiting - verified April 2016

Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent

Conditions:   Coronary Artery Disease;   Coronary Heart Disease;   Stable Angina;   Unstable Angina;   ST-segment Elevation Myocardial Infarction;   Non-ST-segment Elevation Myocardial Infarction
Interventions:   Device: Osiro Hybrid Drug-Eluting Stent;   Device: Resolute Integrity
Sponsors:   Seoul National University Bundang Hospital;   Jeju National University Hospital;   Chungbuk National University Hospital;   SMG-SNU Boramae Medical Center;   Korea University;   Inje University;   Kyung Hee University Hospital at Gangdong;   Inha University Hospital
Completed - verified April 2016

Intracardiac CD133+ Cells in Patients With No-option Resistant Angina

Condition:   Stable Angina
Interventions:   Biological: intramyocardial injection (electromechanical mapping based);   Biological: Placebo
Sponsor:   Medical University of Silesia
Recruiting - verified April 2016

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Condition:   Acute Coronary Syndrome
Interventions:   Drug: alirocumab;   Drug: placebo
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Recruiting - verified April 2016

Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

Conditions:   Obesity;   Overweight
Interventions:   Drug: NB32;   Drug: PBO;   Behavioral: Weight Management Program
Sponsor:   Orexigen Therapeutics, Inc
Terminated - verified April 2016

Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease

Condition:   Atherosclerotic Coronary Vascular Disease
Intervention:   Drug: Ranolazine
Sponsor:   Novartis Pharmaceuticals
Terminated - verified April 2016

Clearance Of Mucus In Stents

Conditions:   Lung Neoplasms;   Respiratory Failure;   Pneumonia;   Acute Coronary Syndromes;   Unstable Angina;   Myocardial Infarction;   Cardiac Arrhythmia;   Thromboembolic Disease
Interventions:   Other: Normal Saline;   Other: Sodium Bicarbonate
Sponsor:   M.D. Anderson Cancer Center
Recruiting - verified April 2016

Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial

Condition:   Coronary Artery Disease
Interventions:   Procedure: follow-up coronary angiography;   Procedure: Clinical follow-up
Sponsor:   Takeshi Morimoto
Active, not recruiting - verified April 2016

Database of Patients Undergoing Cardiac Computed Tomographic Angiography at William Beaumont Hospital (CT DATABASE)

Conditions:   Acute Coronary Syndrome;   Chest Pain
Intervention:  
Sponsor:   Kavitha Chinnaiyan
Active, not recruiting - verified April 2016